A new drug developed by scientists at the Florey Institute of Neuroscience, and the School of Chemistry and Bio21 Institute at the University of Melbourne has dramatically improved clinical and cognitive symptoms of motor neurone disease, also called amyotrophic lateral sclerosis.
Motor neurone disease is a progressive, fatal neurodegenerative disease. Its key hallmark is the death of the brain cells that control muscle movements. This results in muscle weakness and eventually paralysis.
Patients usually die of respiratory failure within three years of diagnosis, and there are no treatments or disease-modifying therapies available.
In this dose-finding trial involving 32 patients, the group given the highest amount of the CuATSM compound showed improved lung function and cognitive ability, compared to the predicted declines observed in standard-of-care patients.
Further, treated patients showed a much slower overall disease progression as measured by a global disability score.
The clinical trial was led by Professor Dominic Rowe at Macquarie University, and Associate Professor Susan Mathers at Calvary Health Care Bethlehem, and sponsored by Collaborative Medicinal Development Pty Ltd with support from FightMND.
Professor Ashley Bush, Chief Scientific Officer of Collaborative Medicinal Development and director of the Melbourne Dementia Research Centre, said “This is the first human evidence for a disease-modifying drug for motor neurone disease. It is a huge breakthrough, and we look forward to confirming the positive results in a larger study soon.”
Associate Professor Kevin Barnham of the Florey, Associate Professor Anthony White at the Queensland Institute of Medical Research, and Professor Paul Donnelly and Associate Professor Peter Crouch from the University of Melbourne, developed and tested CuATSM over a 15-year period.
After showing its therapeutic potential for motor neurone disease in pre-clinical models, the researchers founded a company and licenced the compound to Collaborative Medicinal Development, to take the drug into human studies.
Professor Donnelly said, “It is gratifying to see such promising results made possible by collaborative fundamental research at the interface between chemistry and biology.”
Learn more: Motor neurone disease breakthrough: Patient trial shows impressive clinical results
The Latest on: Motor neurone disease
[google_news title=”” keyword=”motor neurone disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Motor neurone disease
- Passing of Paul Lannon (53) who defied Motor Neurone Disease for 13 yearson March 29, 2024 at 4:34 am
Paul Lannon pictrured with President Michael D Higgins a few years ago. Paul Lannon, the Dunleer man who courageously battled Motor Neurone Disease for 13 years, has died aged 53. Originally from Co ...
- New test detects motor neurone disease before symptomson March 28, 2024 at 11:00 pm
Scientists developing a groundbreaking test have lauded it as a 'game changer' for its ability to identify indicators of motor neurone disease (MND) ...
- 'Game-changer' test spots signs of motor neurone disease before symptomson March 28, 2024 at 2:00 pm
The Irish Motor Neurone Disease Assoication welcomed the 'encouraging' news of the TDP-43 aptamer's ability to detect damaged cell proteins in brain tissue samples ...
- New tool detects signs of motor neuron disease before symptoms beginon March 28, 2024 at 8:32 am
Scientists from the University of Aberdeen in collaboration with the University of Edinburgh and international partners, have identified a new way to detect signs of motor neuron disease (MND) in ...
- ‘Game-changer’ test spots signs of motor neurone disease before symptoms – studyon March 28, 2024 at 8:05 am
A test that spots signs of motor neurone disease before symptoms appear has been hailed a “game changer” by scientists developing it. The tool, known as TDP-43 aptamer, is able to detect damaged cell ...
- Test could give early warning of motor neuron diseaseon March 28, 2024 at 3:56 am
Scientists have developed a new test for a biomarker in brain tissue that could detect people who will go on to develop motor neuron disease (MND) before they show symptoms.
- Motor neurone disease breakthrough as test spots signs even before symptomson March 27, 2024 at 9:06 pm
A test that spots signs of motor neurone disease before symptoms appear has been hailed a “game changer” by scientists developing it. The tool, known as TDP-43 aptamer, is able to detect damaged cell ...
- 'Game changer' test could spot signs of motor neurone disease earlieron March 27, 2024 at 6:41 pm
The research has "exciting potential" to diagnose people earlier - which could make treatments more effective, says the Motor Neurone Disease Association.
- New 'gamer changer' test spots signs of motor neurone disease before symptoms appearon March 27, 2024 at 5:01 pm
A test that spots signs of motor neurone disease before symptoms appear has been hailed a "game changer" by scientists developing it. The tool, known as TDP-43 aptamer, is able to detect damaged cell ...
- Former Mayo GAA star Ger Brady dies after battle with Motor Neurone Diseaseon March 22, 2024 at 1:32 pm
MAYO GAA was plunged into mourning after the sad passing of Ger Brady. The 44-year-old died yesterday at the Mayo Hospice following a lengthy battle with Motor Neurone Disease. It was in August ...
via Bing News